Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 861-869

  Bradford Kline, J ^a   Collins, Carleen M ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; EXOTOXIN; HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN;

ALLELE; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTERIUM MUTANT; BINDING AFFINITY; HOST CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; L CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE ACTIVATION; TOXIC SHOCK SYNDROME;

EID: 13344259321     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.861-869.1996     Document Type: Article

References (43)

1. Abe, J., J. Forrester, T. Nakahara, and J. A. Lafferty. 1991. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol. 146:3747-3750.
2. Alouf, J. E., H. Knoll, and W. Kohler. 1991. Sourcebook of bacterial protein toxins, p. 367-414 Academic Press, Inc., San Diego, Calif.
3. Barsumian, E. L., P. M. Schlievert, and D.W. Watson. 1978. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun 22:681-688.
4. Barter, T., A. Dascal, K. Carroll, and F. J. Curley. 1988. Toxic strep syndrome. a manifestation of group A streptococcal infection Arch. Intern. Med 148:1421-1424.
5. Beharka, A., J. W. Armstrong, J. J. Iandolo, and S. K. Chapes. 1994. Binding and activation of major histocompatibility complex class II-deficient macrophages by Staphylococcus exotoxins. Infect. Immun. 62:3907-3915.
6. Betley, M. J., D. W. Borst, and L. B. Regassa. 1992. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology Chem. Immunol. 53:1-35
7. Bisno, A. L. 1990. Streptococcus pyogenes, p. 1519-1528. In G. L. Mandell, R. G Douglas, and J E. Bennett (ed), Principles and practice of infectious diseases. Churchill Livingstone, New York.
8. Bisno, A. L. 1991 Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med 325:783-793
9. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251-272
10. Braun, M. A., D. Gerlach, U. F. Hartwig, J. H. Ozegowski, F. Romagne, S. Carrel, W. Kohler, and B. Fleischer. 1993. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J. Immunol. 150:2457-2466.
11. Cantor, H., A. L. Crump, V. K. Raman, H. Liu, J. S. Markowitz, M. J. Grusby, and L. H. Glimcher. 1993. Immunoregalatory effects of superantigens: interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol. Rev. 131:21-42
12. T12. Cunningham, C. M., E. L. Barsumian, and D. W. Watson. 1976. Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect. Immun. 14:767-775.
13. Fraser, J. D. 1989. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature (London) 339:221-223
14. Hartwig, U. F., and B. Fleischer. 1993 Mutations affecting MIIC class II binding of the superantigen streptococcal crythrogenic toxin A. Eur. J. Immunol 5:869-875.
15. Hartwig, U. F., D. Gerlach, and B. Fleischer. 1994. Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A. Med Microbiol. Immunol 183:257-264.
16. Hauser, A. R., D. L. Stevens, E. L. Kaplan, and P. M. Schlievert. 1991. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome J. Clin. Microbiol 29:1562-1567.
17. Ho, S. N., H. D. Hunt, R. M. Hortin, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using polymerase chain reaction. Gene 77:51.
18. Hoge, C. W., B. Schwartz, D. F. Talkington, R. F. Breiman, E. M. MacNeill, and S. J. Englender. 1993. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269:384-389.
19. Imanishi, K., H. Igarashi, and T. Uchiyama. 1992. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect. Immun 60:5025-5029.
20. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. Chi, C. Sfuffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule molecule complexed with superantigen. Nature (London) 368:711-718.
21. Kamezawa, Y., and T. Nakahara. 1989. Purification and characterization of streptococcal erythrogenic toxin type A produced by Streptococcus pyogenes strain NY-5 cultured in the synthetic medium NCTC-135. Microbiol Immunol. 33:183-194.
22. Kappler, J. W., A. Herman, J. Clements, and P. Marrack,1992. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp. Med. 173:387-396.
23. Kaufman, J., J. Salomonsen, and M. Flajnik. 1994. Evolutionary conservation of MHC class I and class II molecules-different yet the same. Semin. Immunol. 6:411-124.
24. Kim, Y. B., and D. W. Watson. 1970. A purified group A streptococcal pyrogenic exotoxin. J. Exp. Med. 131:611-628.
25. Klohe, E. P., R. Watts, M. Bahl, C. Alber, W. Yu, R. Anderson, J. Silver, P. K. Gregersen, and R. W. Karr. 1988 Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J. Immunol 141:2158-2164.
26. Lee, P. K., and P. M. Schlievert. 1989. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J. Clin. Microbiol 27:1890-1892.
27. Leonard, B. A. B., P. K. Lee, M. K. Jenkins, and P. M. Schlievert. 1991. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infect. Immun 59:1210-1214
28. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
29. Massell, B. F., C. G. Chute, A. M. Walker, and G. S. Kurland. 1988 Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N. Engl J. Med. 318:280-286.
30. Mollick, J. A., M. Chintagumpala, R. G. Cook, and R. R. Rich. 1991 Staphylococcal exotoxin activation of T cells. J. Immunol. 146:463-468.
31. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases, clonal diversity and pyrogenic exotoxin expression Proc Natl. Acad. Sci. USA 88:2668-2672
32. Musser, J. M., V. Kapur, S. Kanjilal, U. Shah, D. M. Musher, N. L. Barg, K. H. Johnston, P. M. Schlievert, J. Henrichsen, D. Gerlach, R. M. Rakita, A. Tanna, B. D. Cookson, and J. C. Huang. 1993. Geographical and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect Dis. 167:337-345.
33. Nauciel, C. J. Blass, R. Mangalo, and M. Raynaud. 1969. Evidence for two molecular forms of streptococcal erythrogenic toxin. Eur J. Biochem. 11:169-174.
34. Nelson, K., P. M. Schlievert, R. K. Selander, and J. M. Musser. 1991 Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) m Streptococcus pyogenes. J. Exp. Med. 174:1271-1274
35. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors Proc. Natl. Acad. Sci. USA 74:5436-5467.
36. Schlievert, P. M. 1993. Role of superantigens in disease. J. Infect. Dis 167:997-1002.
37. Segel, I. H. 1976. Biochemical calculations, p. 246-252. John Wiley & Sons, Inc., New York.
38. Stevens, D. L. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis 14:2-13.
39. 38a Swaminathan, S., and M. Sax. Unpublished data
40. Tomai, M. A., P. M. Schlievert, and M. Kotb. 1992. Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein Infect. Immun. 60:701-705.
41. Weeks, C. R., and J. J. Ferretti. 1984. The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12 Infect. Immun. 46:531-536.
42. Weeks, C. R., and J. J. Ferretti. 1986 Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12 Infect. Immun. 52:144-150.
43. Yu, C.-E., and J. J. Ferretti. 1991. Molecular characterization of new group A streptococcal bacteriophages containing the gene for streptococcal erythrogenic toxin A (speA). Mol. Gen. Genet. 231:161-168.